Pharmaceuticals
Healthcare
Sun Pharma enters dermatology segment to expand OTC business
Sun Pharmaceutical Industries Ltd on Wednesday announced its entry into the dermatology segment with the launch of its sunscreen product ......
Healthcare
Govt may ease FDI cap for existing drugmakers
Government is considering a proposal to relax foreign direct investment (FDI) norms in existing pharmaceutical companies with a view to ......
Healthcare
Cipla hires Kedar Upadhye from Dr Reddy's Labs as global CFO
Mumbai-based drugmaker Cipla Ltd said on Wednesday it has appointed Kedar Upadhye, a top executive from Dr Reddy's Laboratories Ltd, ......
Healthcare
Laurus Labs recorded steep decline in revenue growth & net profit in FY15
Vishakhapatnam-based drug ingredients maker Laurus Labs, which has true-blue private equity firm Warburg Pincus on board as an investor and ......
Healthcare
Sun Pharma sells two US manufacturing units to Frontida BioPharm
Sun Pharmaceutical Industries Ltd has sold two oral solid dosage manufacturing facilities in the US to Frontida BioPharm Inc, as ......
Healthcare
Shilpa Medicare to acquire remaining stake in Nu Therapeutics
Pharmaceutical ingredients manufacturer Shilpa Medicare Ltd has received approval from its board to acquire the remaining stake in Hyderabad-based Nu ......
Healthcare
SeQuent Scientific's arm to buy 60% stake in Spain's Karizoo Group
Pharmaceutical company SeQuent Scientific Ltd said its subsidiary Alivira Animal Health Ltd will acquire a majority stake in Spanish animal ......
Pharmaceuticals
RPG Life Sciences sells biotech business to Intas Pharma
Mumbai-based RPG Life Sciences Ltd, an integrated pharmaceutical firm operating in the domestic and international markets in the branded formulations, ......
Healthcare
Dr. Reddy's acquires six consumer healthcare OTC brands in US
Dr. Reddy's Laboratories Ltd has acquired a portfolio of half a dozen over-the-counter (OTC) drug brands from American drugmaker Ducere ......
Healthcare
Bayer's $62 bn buyout bid for Monsanto triggers open offer rally in Indian listed arm
German pharmaceutical and chemicals giant Bayer AG has made a $62 billion offer to buy US-based seed conglomerate Monsanto Co, ......